Manufacturer
54 recalls in our database name RAYSEARCH LABORATORIES AB as the manufacturing or recalling firm.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
RayCare 2024A SP4 oncology information system may lose data or fail to notify users when beam set delivery notes are modified simultaneously or updated during treatment sessions.
RayCare 2024A SP1 oncology software may lose data if beam set delivery notes are modified simultaneously or updated during treatment sessions, with users not notified of changes.
Pending LLM rewrite. Source: FDA_DEVICE Z-1110-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1109-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1105-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1103-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1107-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1104-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1102-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1108-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1106-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-2493-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2492-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2495-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2490-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2491-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2489-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2488-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2487-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-2494-2025.
RayStation radiation therapy planning software versions 4.5 through 2024B contain an inconsistency in density uncertainty handling when HU-to-mass density CT calibration curves are used. No illnesses or injuries have been reported.
RayStation radiation therapy planning software is being recalled due to inconsistent handling of density uncertainty in dose calculations for proton and light ion treatment plans. The software defect may affect the accuracy of calculated radiation doses.
RayStation radiation therapy planning software contains an inconsistency in density uncertainty calculations within dose planning functions affecting proton and light ion treatments in versions 4.5 through 2024B.
RayStation radiation therapy treatment planning software contains an inconsistency in density uncertainty calculations that may affect dose accuracy for proton and light ion treatments. The issue affects systems using HU-to-mass density CT calibration curves from RayStation versions 4.5 through 2024B.
RayStation radiation therapy planning software versions 4.5 through 2024B contain an inconsistency in how density uncertainty is handled in dose calculation functions for proton and light ion therapy plans.